MAP2K3 and central nervous system cancer: MAP2K3 is expressed in various glioma cell lineages and its expression is most abundant in immune and malignant cells, of which we show representative single cell sequencing datasets (GSE102130, GSE163108_10X, and GSE148842) (Figures 8B–D).